Article Text
Review
Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus
Abstract
Some patients with type 2 diabetes mellitus (T2DM) are profoundly insulin resistant and require large insulin doses to achieve optimal glycaemic control. However, large volumes of subcutaneous conventional U-100 insulin can cause discomfort at the injection site, resulting in poor concordance with insulin therapy. One therapeutic option is the use of U-500 insulin, thus reducing the insulin volume by 80%. This review will address the practical issues associated with the use of U-500, clinical efficacy and safety aspects of this concentrated insulin, which has an important role in a subgroup of patients with T2DM.
- insulin
- U-500
- type 2 diabetes
- insulin resistance
Statistics from Altmetric.com
Footnotes
Competing interests: None declared.